|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.50 CNY | -1.01% |
|
-5.25% | +1.56% |
| 01-13 | Hengrui Pharma Unit Secures Approval to Conduct Clinical Trial for Hypertension Drug | MT |
| 01-13 | Hengrui Pharma's Cancer Drug Obtains China Breakthrough Therapy Designation | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 64.52 | 72.47 | 72.47 |
| Spread/Res. | -6.23% | -16.52% | -16.52% |
| Spread/Supp. | +2.28% | +7.27% | +7.27% |
| Support | 59.15 | 56.4 | 56.4 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- 600276 Stock
- Charts Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition